Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes

Background: Inter-individual differences in opioid sensitivity may underlie different opioid risk profiles but have often been researched in persons who have current or past opioid use disorder or physical dependence. This study examined how opioid sensitivity manifests across various assessments of...

Full description

Bibliographic Details
Main Authors: Caitlyn J. Durgin, Andrew S. Huhn, Cecilia L. Bergeria, Patrick H. Finan, Claudia M. Campbell, Denis G. Antoine, Kelly E. Dunn
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724623000586
_version_ 1827815994062536704
author Caitlyn J. Durgin
Andrew S. Huhn
Cecilia L. Bergeria
Patrick H. Finan
Claudia M. Campbell
Denis G. Antoine
Kelly E. Dunn
author_facet Caitlyn J. Durgin
Andrew S. Huhn
Cecilia L. Bergeria
Patrick H. Finan
Claudia M. Campbell
Denis G. Antoine
Kelly E. Dunn
author_sort Caitlyn J. Durgin
collection DOAJ
description Background: Inter-individual differences in opioid sensitivity may underlie different opioid risk profiles but have often been researched in persons who have current or past opioid use disorder or physical dependence. This study examined how opioid sensitivity manifests across various assessments of opioid effects in a primarily opioid-naïve population. Procedures: Data were harmonized from two within-subject, double-blind trials wherein healthy participants (N = 123) received placebo and 4 mg oral hydromorphone. Demographics, self-report ratings, observer ratings, physiological, and cold pressor measures were collected. Participants were categorized as being responsive or nonresponsive to the opioid dose tested and compared using mixed-models, Pearson product correlations, and paired t-tests. Findings: Participants were 49.6% female, mean 33.0 (SD=9.3) years old, and 44.7% Black/African American and 41.5% White, with 89.4% reporting no prior exposure to opioids. Within-subject sensitivity to opioids varied depending on the measure. One in five participants did not respond subjectively to the 4 mg hydromorphone dose based on their “Drug Effects” rating. Persons who were responsive showed more evidence of drug-dependent effects than did persons who were not responsive on ratings of Bad Effects (p= .03), feeling High (p= .01), Nausea (p= .03), pupil diameter (p< 0.01), and on the circular lights task (p< 0.001). Conclusions: This study provides initial evidence that the experience of opioids may be domain specific. Data suggest potentially clinically meaningful differences exist regarding opioid response patterns, evident following one dose among opioid inexperienced individuals.
first_indexed 2024-03-12T00:08:35Z
format Article
id doaj.art-d3a1a58b798c4e5f9572a826c1abcfad
institution Directory Open Access Journal
issn 2772-7246
language English
last_indexed 2024-03-12T00:08:35Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Drug and Alcohol Dependence Reports
spelling doaj.art-d3a1a58b798c4e5f9572a826c1abcfad2023-09-16T05:32:05ZengElsevierDrug and Alcohol Dependence Reports2772-72462023-09-018100188Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomesCaitlyn J. Durgin0Andrew S. Huhn1Cecilia L. Bergeria2Patrick H. Finan3Claudia M. Campbell4Denis G. Antoine5Kelly E. Dunn6Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr, Baltimore MD 21224, USADepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr, Baltimore MD 21224, USADepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr, Baltimore MD 21224, USADepartment of Anesthesiology, University of Virginia, Charlottesville, VA, USADepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr, Baltimore MD 21224, USADepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr, Baltimore MD 21224, USADepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Dr, Baltimore MD 21224, USA; Corresponding author.Background: Inter-individual differences in opioid sensitivity may underlie different opioid risk profiles but have often been researched in persons who have current or past opioid use disorder or physical dependence. This study examined how opioid sensitivity manifests across various assessments of opioid effects in a primarily opioid-naïve population. Procedures: Data were harmonized from two within-subject, double-blind trials wherein healthy participants (N = 123) received placebo and 4 mg oral hydromorphone. Demographics, self-report ratings, observer ratings, physiological, and cold pressor measures were collected. Participants were categorized as being responsive or nonresponsive to the opioid dose tested and compared using mixed-models, Pearson product correlations, and paired t-tests. Findings: Participants were 49.6% female, mean 33.0 (SD=9.3) years old, and 44.7% Black/African American and 41.5% White, with 89.4% reporting no prior exposure to opioids. Within-subject sensitivity to opioids varied depending on the measure. One in five participants did not respond subjectively to the 4 mg hydromorphone dose based on their “Drug Effects” rating. Persons who were responsive showed more evidence of drug-dependent effects than did persons who were not responsive on ratings of Bad Effects (p= .03), feeling High (p= .01), Nausea (p= .03), pupil diameter (p< 0.01), and on the circular lights task (p< 0.001). Conclusions: This study provides initial evidence that the experience of opioids may be domain specific. Data suggest potentially clinically meaningful differences exist regarding opioid response patterns, evident following one dose among opioid inexperienced individuals.http://www.sciencedirect.com/science/article/pii/S2772724623000586OpioidHeroinOpioid sensitivityCold pressorOpioid naïvePersonalized medicine
spellingShingle Caitlyn J. Durgin
Andrew S. Huhn
Cecilia L. Bergeria
Patrick H. Finan
Claudia M. Campbell
Denis G. Antoine
Kelly E. Dunn
Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
Drug and Alcohol Dependence Reports
Opioid
Heroin
Opioid sensitivity
Cold pressor
Opioid naïve
Personalized medicine
title Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
title_full Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
title_fullStr Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
title_full_unstemmed Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
title_short Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
title_sort within subject double blind examination of opioid sensitivity in participant reported observed physiologic and analgesic outcomes
topic Opioid
Heroin
Opioid sensitivity
Cold pressor
Opioid naïve
Personalized medicine
url http://www.sciencedirect.com/science/article/pii/S2772724623000586
work_keys_str_mv AT caitlynjdurgin withinsubjectdoubleblindexaminationofopioidsensitivityinparticipantreportedobservedphysiologicandanalgesicoutcomes
AT andrewshuhn withinsubjectdoubleblindexaminationofopioidsensitivityinparticipantreportedobservedphysiologicandanalgesicoutcomes
AT cecilialbergeria withinsubjectdoubleblindexaminationofopioidsensitivityinparticipantreportedobservedphysiologicandanalgesicoutcomes
AT patrickhfinan withinsubjectdoubleblindexaminationofopioidsensitivityinparticipantreportedobservedphysiologicandanalgesicoutcomes
AT claudiamcampbell withinsubjectdoubleblindexaminationofopioidsensitivityinparticipantreportedobservedphysiologicandanalgesicoutcomes
AT denisgantoine withinsubjectdoubleblindexaminationofopioidsensitivityinparticipantreportedobservedphysiologicandanalgesicoutcomes
AT kellyedunn withinsubjectdoubleblindexaminationofopioidsensitivityinparticipantreportedobservedphysiologicandanalgesicoutcomes